Pharmafile Logo
Pharmafocus logo
Advanced Search

CSL receives positive results from rare disease drug phase 3 trial

February 28, 2023
Research and Development

Biotech company CSL has reported positive results from its phase 3 trial for garadacimab, a monthly treatment for hereditary angioedema …

News

MHRA’s authority restored following Northern Ireland Brexit deal

February 28, 2023
Medical Communications

The Medicines and Healthcare products Regulatory Agency (MHRA) has been limited to approving medicines in Great Britain (England, Scotland and …

News

Rare and orphan disease expert Terebellum launches market access guide

February 28, 2023
Business Services

Terebellum, subsidiary of global specialty pharmacy and healthcare solutions organisation AscellaHealth, is launching a strategic guide to help manufacturers bring …

News
Press release

Rare disease community call for their unified voice to be heard in the fight for equitable care

February 28, 2023
Business Services

Reading, 28th February 2023.

News
Press release

PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)

February 27, 2023
Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …

News
Press release

Almirall opens the doors of its R&D centre to the biotech ZeClinics

February 27, 2023
Business Services

BARCELONA, Spain. February 27th 2023 – Almirall, a global biopharmaceutical company focused on skin health, today announced an agreement with …

News
Press release

HUTCHMED Completes Patient Enrollment of Phase II Registration Trial of Amdizalisib in Follicular Lymphoma in China

February 27, 2023
Business Services

Hong Kong, Shanghai & Florham Park, NJ — Monday, February 27, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM, HKEX:​13) today announces …

News
Press release

CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System

February 27, 2023
Business Services

Cambridge, UK, 27 February 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems …

News
Press release

Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment

February 27, 2023
Business Services

Cambridge, UK, 27 February 2023: Five Alarm Bio (FAB), a drug discovery company focused on novel approaches to anti-aging, announced …

News
Press release

FDA sued by US states over abortion pill access

February 27, 2023
Medical Communications

Attorneys general (AGs) from 12 Democrat-led US states have made complaints to the FDA in an attempt to force the …

News

Causeway Therapeutics raises £8.75m for tennis elbow research

February 27, 2023
Medical Communications

University of Glasgow spin-out Causeway Therapeutics has announced that it has raised £8.75m from investors, which will fund an international …

News

AbbVie gains positive CHMP opinion for upadacitinib for the treatment of Crohn’s disease

February 27, 2023
Medical Communications

AbbVie has announced that it has received positive feedback from the EMA’s Committee for Medicinal Products for Human Use (CHMP) …

News

Merck to appeal EU rejection of COVID-19 drug

February 27, 2023
Medical Communications

Life science giant Merck & Co has announced that it will appeal the EU’s Committee for Medicinal Products for Human …

News

Incyte Announces Positive CHMP Opinion for Ruxolitinib Cream (Opzelura™) for the Treatment of Non-segmental Vitiligo in Adults and Adolescents

February 24, 2023
Business Services

WILMINGTON, Del. – February 24, 2023 – Incyte (Nasdaq:INCY) today announced that the European Medicines Agency (EMA) Committee for Medicinal …

News
Press release

Janssen Receives Positive CHMP Opinion for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) Plus Prednisone or Prednisolone for the Treatment of Adult Patients with BRCA1/2 Gene-Mutated Metastatic Castration Resistant Prostate Cancer

February 24, 2023
Business Services

BEERSE, Belgium, 24 February 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for …

News
Press release

Automata launches the LINQ platform to fully automate workflows and the transport of labware in every lab space

February 24, 2023
Business Services

24th February 2023 – Automata, a leading automation company powering life science labs to fully automate their workflows, today launches

News
Press release

AviadoBio Signs Exclusive License Agreement with Neurgain Technologies for Novel Gene Therapy Spinal Delivery Technology

February 24, 2023
Business Services

LONDON–(BUSINESS WIRE)–AviadoBio, a pioneering gene therapy company developing and delivering transformative medicines for neurodegenerative disorders and Neurgain Technologies, Inc., an …

News
Press release

Sanofi and Glooko partner on ‘connected insulin’ tech

February 24, 2023
Medical Communications

Big pharma company Sanofi aims to develop insulin-based therapies that can be connected with glucose monitoring devices, making it easier …

News

Mologic Inc’s COVID-19 rapid antigen self-test receives FDA Emergency Use Authorization for home use

February 24, 2023
Medical Communications

US subsidiary of Global Access Diagnostics (GADx) ‒ a developer of lateral flow and rapid diagnostic technologies, products and services …

News

NICE approved BMS’s Opdivo for lung cancer

February 24, 2023
Medical Communications

Bristol-Myers Squibb’s (BMS) immunotherapy drug Opdivo (nivolumab) has become the first to be cleared for NHS use alongside chemotherapy as …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026